Elevated CD21(low) B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency

PURPOSE: Limited data is available on the effect of COVID-19 vaccination in immunocompromised individuals. Here, we provide the results from vaccinating a single-center cohort of patients with common variable immunodeficiency (CVID). METHODS: In a prospective, open-label clinical trial, 50 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergman, Peter, Wullimann, David, Gao, Yu, Wahren Borgström, Emilie, Norlin, Anna-Carin, Lind Enoksson, Sara, Aleman, Soo, Ljunggren, Hans-Gustaf, Buggert, Marcus, Smith, C. I. Edvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922070/
https://www.ncbi.nlm.nih.gov/pubmed/35290571
http://dx.doi.org/10.1007/s10875-022-01244-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922070/
https://www.ncbi.nlm.nih.gov/pubmed/35290571
http://dx.doi.org/10.1007/s10875-022-01244-2

Ejemplares similares